EGFR and head and neck squamous cell carcinoma: Based on stable long-term CAR expression, lack of tonic signaling (Supplementary Figure S3) and HNSCC killing activity, anti-HER1 CAR-NK-92 cell variants 12D3 CH3 and 2F8 CH3 were selected as the most promising candidates and used for all further experiments.